Skip to main content

FDA 預測與賠率

·
FDA批準Outlook Therapeutics的ONS-5010 ?

FDA批準Outlook Therapeutics的ONS-5010 ?

85%

$4.9K 交易量

$4.9K Liq.

Ends 25 天內

FDA今年批準Retatrutide ?

FDA今年批準Retatrutide ?

14%

$575K 交易量

$4.5K Liq.

3

Ends 6 個月內

特朗普將宣布誰成為下一任FDA委員?

特朗普將宣布誰成為下一任FDA委員?

28%

Kyle Diamantas

$13.7K 交易量

$13.3K Liq.

Ends 6 個月內

FDA批準Viatris的低劑量雌激素每週貼劑?

FDA批準Viatris的低劑量雌激素每週貼劑?

88%

$1.7K 交易量

$3.1K Liq.

Ends 27 天內

FDA批準賽諾菲的皮下Sarclisa ?

FDA批準賽諾菲的皮下Sarclisa ?

89%

$3.0K 交易量

$2.9K Liq.

Ends 19 天內

FDA通過以下方式將BPC-157移至第1類… ?

FDA通過以下方式將BPC-157移至第1類… ?

32%

2026年8月31日

$933 交易量

$961 Liq.

Ends 6 個月內

FDA批準大塚的Centanafadine ?

FDA批準大塚的Centanafadine ?

66%

$75 交易量

$101 Liq.

Ends 20 天內

FDA今年批準了Daraxonrasib ?

FDA今年批準了Daraxonrasib ?

75%

$318 交易量

$854 Liq.

Ends 6 個月內

FDA批準Arcalyst技術轉讓?

FDA批準Arcalyst技術轉讓?

11%

$5.7K 交易量

$265 Liq.

Ends 15 天前

FDA approves Celcuity's Gedatolisib?

FDA approves Celcuity's Gedatolisib?

73%

$0 交易量

$106 Liq.

Ends 13 天內

FDA批準Vera Therapeutics的Atacicept ?

FDA批準Vera Therapeutics的Atacicept ?

88%

$431 交易量

$79 Liq.

Ends 3 天內

FDA批準Elevar Therapeutics的Rivoceranib + camrelizumab ?

FDA批準Elevar Therapeutics的Rivoceranib + camrelizumab ?

59%

$20 交易量

$66 Liq.

Ends 19 天內

FDA批準MannKind的FUROSCIX ReadyFlow自動注射器?

FDA批準MannKind的FUROSCIX ReadyFlow自動注射器?

42%

$176 交易量

$36 Liq.

Ends 22 天內

Hantavirus vaccine in 2026?

Hantavirus vaccine in 2026?

6%

$126K 交易量

$36.3K Liq.

7

Ends 6 個月內

Frequently Asked Questions

Polymarket is the world’s largest prediction market, where you can stay informed and profit from your knowledge by trading on things related to breaking news, politics, sports, elections, crypto, finance, tech, culture, including topics like FDA.

Polymarket currently hosts 14 active markets for FDA that lets you track or trade on predictions like “FDA批準Outlook Therapeutics的ONS-5010 ?”. Whether you are tracking widely debated events or niche outcomes, the platform aggregates real-time odds based on over $732K in trading volume, providing a comprehensive view of fan and investor sentiment.

Each polymarket is a yes/no question, like “Hantavirus vaccine in 2026? ”. You buy shares in “yes” or “no” outcomes. Prices reflect crowd-sourced odds and probabilities. For example, if yes is at 30 cents, that’s a 30% chance. Markets resolve based on official results. For multi-outcome events, like “特朗普將宣布誰成為下一任FDA委員?,” you simply trade on the specific outcome you think will win.

As of today, the most active market is “FDA今年批準Retatrutide ?,” where the crowd is currently assigning a 86% chance to No. These odds update in real-time as new information emerges and users trade, offering a dynamic snapshot of what the market believes will happen compared to traditional bookmaker odds.

It cuts through the noise. Unlike polls or punditry, Polymarket shows you real-time odds on FDA predictions backed by financial conviction that are often faster and more accurate than experts or surveys. You get an unbiased view of what thousands of traders think will actually happen, often more accurate than polls. Plus, you can trade shares and potentially profit if your predictions are spot on.